NCT03626922 2022-06-10
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
NSABP Foundation Inc
Phase 1 Unknown
NSABP Foundation Inc
NSABP Foundation Inc
Korean South West Oncology Group
Korean South West Oncology Group